NCT02301858 Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases Status ACTIVE_NOT_RECRUITING Phase NA
NCT02156700 Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors Status COMPLETED Phase N/A
NCT02036008 Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial Status UNKNOWN Phase NA
NCT01918852 S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. Status COMPLETED Phase PHASE3
NCT01844661 Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. Status COMPLETED Phase PHASE1/PHASE2
NCT01759238 Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01678664 Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors Status COMPLETED Phase PHASE2
NCT01442246 Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01403324 Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer Status TERMINATED Phase NA
NCT01325142 Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer Status COMPLETED Phase N/A
NCT01231347 QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE3
NCT01213758 Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT Status COMPLETED Phase N/A
NCT01169129 Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases Status WITHDRAWN Phase PHASE3
NCT01091168 Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00807859 Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00802659 A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain Status TERMINATED Phase NA
NCT00770536 AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR Status COMPLETED Phase PHASE1
NCT00752570 A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma Status COMPLETED Phase PHASE2